Working out of a tribal-owned hospital in Anchorage, Alaska, liver specialist Brian McMahon has spent decades treating the ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...

Of the 723 people with Fibrosis-4 Index scores greater than 3.25, indicating advanced fibrosis, and 587 people with diagnosed ...

HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens ...

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend ...

The CDC’s vaccine advisors, led by a newly named chair, will discuss making more changes to the childhood vaccine schedule ...

Despite untreated HBV being linked to earlier mortality, higher all-cause and liver-related death, and a 10% to 25% lifetime risk of developing hepatocellular carcinoma (HCC), only 29% of qualifying ...